Viridian Therapeutics (VRDN)
(Delayed Data from NSDQ)
$13.47 USD
-1.37 (-9.23%)
Updated Sep 5, 2024 04:00 PM ET
After-Market: $13.48 +0.01 (0.07%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Brokerage Reports
0 items in cart
Viridian Therapeutics, Inc. [VRDN]
Reports for Purchase
Showing records 1 - 20 ( 94 total )
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Eyes On Target -- Looking Ahead To THRIVE Data In September
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Viridian Remains on Track With THRIVE Readout on the Horizon; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
REVEALing Its Plans For SC VRDN-003 --- Pivotals Start August, BLA By 2026
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
We Are Confident in VRDN-001''s Efficacy, But Being Conservative With the TED Market Size
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Execution Matters -- THRIVE Setting Up For ~September, THRIVE-2 YE24
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
TED KOL Check: Untangling The TED Therapeutic Landscape
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
INVITE: TED KOL Check -- Untangling The TED Therapeutic Landscape
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Make Sure To Read Fine Print; Lonigutamab Update/Read Through To VRDN
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Viridian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Pipeline Continues to THRIVE --- Awaiting Pivotal Data By Mid-2024
Provider: Wedbush Securities Inc.
Analyst: CHICO L